Open AccessCorrection: Predominant Expression of CCL2 at the Tumor Site of Prostate Cancer Patients Directs a Selective Loss of Immunological Tolerance to CCL2 That Could Be Amplified in a Beneficial Manner
Author(s) -
Liat Izhak,
Gizi Wildbaum,
Uri Weinberg,
Yuval Shaked,
Jennifer Alami,
Daniel Dumont,
Boris Friedman,
Avi Stein,
Nathan Karin
Publication year - 2018
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1800167
Subject(s) - ccl2 , prostate cancer , expression (computer science) , cancer research , cancer , medicine , computer science , chemokine , receptor , programming language
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom